PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $9,000 | -73.5% | 19,479 | -75.1% | 0.00% | -50.0% |
| Q1 2019 | $34,000 | +17.2% | 78,174 | -14.9% | 0.00% | 0.0% |
| Q4 2018 | $29,000 | -37.0% | 91,862 | +44.4% | 0.00% | -33.3% |
| Q3 2018 | $46,000 | +360.0% | 63,626 | +180.4% | 0.00% | – |
| Q2 2018 | $10,000 | -58.3% | 22,691 | -37.0% | 0.00% | -100.0% |
| Q4 2017 | $24,000 | +41.2% | 35,994 | +22.2% | 0.00% | 0.0% |
| Q3 2017 | $17,000 | – | 29,455 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,825,000 | $1,206,000 | 0.39% |
| Zhang Financial LLC | 45,000 | $33,000 | 0.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 472,553 | $313,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 127,062 | $85,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $215,000,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $200,000 | 0.00% |
| Renaissance Technologies | 1,993,500 | $1,318,000 | 0.00% |
| WEDBUSH SECURITIES INC | 15,000 | $10,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 57,127 | $38,000 | 0.00% |
| Psagot Value Holdings Ltd. | 29,193 | $20,000 | 0.00% |